These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36387815)

  • 1. Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: A meta-analysis.
    Wang JL; Xiang BX; Song XL; Que RM; Zuo XC; Xie YL
    World J Clin Cases; 2022 Nov; 10(31):11466-11485. PubMed ID: 36387815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury.
    Sisay M; Hagos B; Edessa D; Tadiwos Y; Mekuria AN
    Pharmacol Res; 2021 Jan; 163():105328. PubMed ID: 33276108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins.
    Wagenlehner F; Lucenteforte E; Pea F; Soriano A; Tavoschi L; Steele VR; Henriksen AS; Longshaw C; Manissero D; Pecini R; Pogue JM
    Clin Microbiol Infect; 2021 Jan; ():. PubMed ID: 33359542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies.
    Oliota AF; Penteado ST; Tonin FS; Fernandez-Llimos F; Sanches AC
    Diagn Microbiol Infect Dis; 2019 May; 94(1):41-49. PubMed ID: 30635223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.
    Aggarwal R; Dewan A
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):15. PubMed ID: 29571295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.
    Phe K; Lee Y; McDaneld PM; Prasad N; Yin T; Figueroa DA; Musick WL; Cottreau JM; Hu M; Tam VH
    Antimicrob Agents Chemother; 2014 May; 58(5):2740-6. PubMed ID: 24566187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.
    Vardakas KZ; Falagas ME
    Int J Antimicrob Agents; 2017 Feb; 49(2):233-238. PubMed ID: 27686609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials.
    Eljaaly K; Bidell MR; Gandhi RG; Alshehri S; Enani MA; Al-Jedai A; Lee TC
    Open Forum Infect Dis; 2021 Feb; 8(2):ofab026. PubMed ID: 33623807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients.
    Deng Y; Gu JY; Li X; Tong H; Guo SW; Xu B; Li Y; Zhang BK; Li Y; Huang HY; Xiao GY
    Infect Dis Ther; 2022 Aug; 11(4):1591-1608. PubMed ID: 35689791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin and polymyxin B for treatment of nosocomial infections in intensive care unit patients: pharmacoeconomic analysis.
    Quintanilha JCF; Duarte NDC; Lloret GR; Visacri MB; Mattos KPH; Dragosavac D; Falcão ALE; Moriel P
    Int J Clin Pharm; 2019 Feb; 41(1):74-80. PubMed ID: 30552622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality.
    Patel A; Laffan MA; Waheed U; Brett SJ
    BMJ; 2014 Jul; 349():g4561. PubMed ID: 25099709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
    Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
    BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.
    Crass RL; Rutter WC; Burgess DR; Martin CA; Burgess DS
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials.
    Kuriyama A; Katsura M; Urushidani S; Takada T
    Ann Transl Med; 2018 Jun; 6(11):206. PubMed ID: 30023369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
    Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
    Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients.
    Ye Q; Wang Q; Chen Z; Chen W; Zhan Q; Wang C
    Clin Respir J; 2022 May; 16(5):402-412. PubMed ID: 35586931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effect of Mannitol on Cisplatin-Induced Nephrotoxicity: A Systematic Review and Meta-Analysis.
    Li S; He X; Ruan L; Ye T; Wen Y; Song Z; Hu S; Chen Y; Peng B; Li S
    Front Oncol; 2021; 11():804685. PubMed ID: 34976843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.